Bookmark! (press Ctrl+D)

Within days, American pharma giant Pfizer has made two big positive announcements on Covid-19 vaccine developments. After declaring 90 per cent effectiveness of the vaccine in the first release on the third stage of the clinical trial of its Covid-19 vaccine, Pfizer has now said its vaccine candidate has achieved 95 per cent effectiveness.

The company, which is developing the Covid-19 vaccine in partnership with German drugmaker BioNTech SE, said there has been no serious safety concerns related to the vaccine.

Pfizer said, “The safety milestone required by the US FDA (Food and Drug Administration) for Emergency Use Authorization (EUA) has been achievedWithin days, we plan to submit a request to the US FDA for an EUA based on the totality of safety and efficacy data collected, as well as manufacturing data relating to the quality and consistency of the vaccine candidate.”

#Pfizer #CovidVaccine #IndiaToday

Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you’ll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!
India Today TV is India’s leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.

Stay tuned for latest updates and in-depth analysis of news from India and around the world!

Download Mobile App from India’s No.1 News Video Publisher : https://indiatoday.app.link/zKoSVVDrnP

Follow us: Official website: https://www.indiatoday.in/

Twitter: https://twitter.com/IndiaToday

Facebook: https://www.facebook.com/IndiaToday

Telegram: https://t.me/indiatodayofficial

source

LEAVE A REPLY

Please enter your comment!
Please enter your name here